Steve Melvyn Howdle
Presidente presso The University of Nottingham
Profilo
Steve Melvyn Howdle was the founder of Critical Pharmaceuticals Ltd., which was founded in 2002, where he held the title of Chief Scientific Officer.
Currently, he holds the position of Chairman at The University of Nottingham.
Posizioni attive di Steve Melvyn Howdle
| Società | Posizione | Inizio |
|---|---|---|
| The University of Nottingham | Presidente | - |
Precedenti posizioni note di Steve Melvyn Howdle
| Società | Posizione | Fine |
|---|---|---|
Critical Pharmaceuticals Ltd.
 Critical Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Critical Pharmaceuticals Ltd. operates as a clinical stage biotechnology company with interest in developing and producing biological drug products. The company product pipeline includes CP024: Nasal hGH, CP046: Nasal PTH, CP016: hGH Depot and CP018: Risperidone. Critical Pharmaceuticals was founded by Steve Howdle and Kevin Morris Shakesheff in 2002 and is headquartered in Nottingham, the United Kingdom. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Critical Pharmaceuticals Ltd.
Critical Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Critical Pharmaceuticals Ltd. operates as a clinical stage biotechnology company with interest in developing and producing biological drug products. The company product pipeline includes CP024: Nasal hGH, CP046: Nasal PTH, CP016: hGH Depot and CP018: Risperidone. Critical Pharmaceuticals was founded by Steve Howdle and Kevin Morris Shakesheff in 2002 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Steve Melvyn Howdle